Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 22, 2024Journal of Associated Medical Sciences

A genetically engineered mouse/human chimeric antibody targeting CD99 enhances antibody-dependent cellular phagocytosis against human mantle cell lymphoma Z138 cells

View Full Paper
Ask AI
Bookmark
Share

Authors

KKKamonporn KotemulSPSupansa PataWLWitida Laopajon

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kotemul et al. (2024) studied this question.

synapsesocial.com/papers/68e63c0bb6db6435875cd828https://doi.org/10.12982/jams.2024.047
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparative In Vitro Apoptotic Activity of Two Chimeric Anti-CD99 Antibodies Recognizing Distinct CD99 Regions in T-ALL Models2026
  2. 2Abstract 5346: A novel humanized CD16A model to evaluate efficacy of human antibody therapeutics in triggering ADCC2024
  3. 3Chimeric and humanized antibodies with specificity for the CD33 antigen1992 · 146 citations
  4. 4Generation and preclinical evaluation of a human heavy-chain-only antibody recognizing the membrane-bound tumor-associated antigen mesothelin2024
  5. 5Transcriptome Analysis Reveals the Induction of Apoptosis-Related Genes by a Monoclonal Antibody against a New Epitope of CD99 on T-Acute Lymphoblastic Leukemia2024 · 2 citations